These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 32380

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antihypertensive effect of intravenously and orally administered bunitrolol (Kö 1366).
    Okabayashi T, Naito S, Arakawa K.
    Arzneimittelforschung; 1979; 29(9):1417-21. PubMed ID: 42418
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical investigation of o-(2-hydroxy-3-(tert.-butylamino)-propoxy)-benzonitrile under glucose load by means of continuous recording].
    Regula H, Papner B.
    Arzneimittelforschung; 1974 Sep; 24(9):1328-30. PubMed ID: 4154767
    [No Abstract] [Full Text] [Related]

  • 5. [The metabolism of 1-tertiary-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker agent. II. Blood level, distribution, and structure of its metabolites in bile (author's transl)].
    Honma S, Kanbekawa A.
    Yakugaku Zasshi; 1975 Jun; 95(6):680-9. PubMed ID: 241825
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A double blind cross-over comparison of bunitrolol and placebo in the treatment of angina pectoris.
    Jonker JJ, de Klerk J, den Ottolander GJ.
    Arzneimittelforschung; 1981 Jun; 31(7):1140-2. PubMed ID: 6115654
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of the new beta-adrenoceptor blocker SL 75212 in man after repeated oral administration [proceedings].
    Bianchetti G, Blatrix C, Gomeni R, Kilborn JR, Larribaud J, Lücker PW, Morselli PL, Thébault JJ, Trocherie S.
    Br J Clin Pharmacol; 1979 Oct; 8(4):408P. PubMed ID: 41560
    [No Abstract] [Full Text] [Related]

  • 10. [The effect of a short-term oral administration of trimepranol on plasma renin activity (author's transl)].
    Slabý A, Dosková M, Horký K, Urbánek J, Reiseauer R.
    Sb Lek; 1975 Apr; 77(4):102-6. PubMed ID: 238277
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Synthesis of 5-(3-tert-butylamino-2-hydroxypropoxy)-8-hydroxy-3,4-dihydrocarbostyril hydrochloride and its beta-adrenergic blocking activity].
    Uchida M, Tominaga M, Oka K, Tone H, Uno T.
    Yakugaku Zasshi; 1976 May; 96(5):571-7. PubMed ID: 9501
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Comparison of the haemodynamic effects in man of the beta-adrenergic blocking substances Kö 1366 and practolol (author's transl)].
    Gloger K.
    Arzneimittelforschung; 1975 Aug; 25(8):1300-3. PubMed ID: 241365
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Blood concentrations and pharmacodynamic effects of SL 75212, a new beta-adrenoceptor antagonist, after oral and intravenous administration [proceedings].
    Bianchetti G, Gomeni R, Kilborn JR, Morselli PL, Taylor EA, Warrington SJ.
    Br J Clin Pharmacol; 1979 Oct; 8(4):403P-404P. PubMed ID: 41556
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.